161 related articles for article (PubMed ID: 15040863)
1. Therapeutic approaches targeting prostate cancer progression using novel voltage-gated ion channel blockers.
Sikes RA; Walls AM; Brennen WN; Anderson JD; Choudhury-Mukherjee I; Schenck HA; Brown ML
Clin Prostate Cancer; 2003 Dec; 2(3):181-7. PubMed ID: 15040863
[TBL] [Abstract][Full Text] [Related]
2. Voltage-gated sodium ion channels in prostate cancer: expression and activity.
Abdul M; Hoosein N
Anticancer Res; 2002; 22(3):1727-30. PubMed ID: 12168861
[TBL] [Abstract][Full Text] [Related]
3. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility.
Fraser SP; Salvador V; Manning EA; Mizal J; Altun S; Raza M; Berridge RJ; Djamgoz MB
J Cell Physiol; 2003 Jun; 195(3):479-87. PubMed ID: 12704658
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
5. Voltage-gated sodium channels: new targets in cancer therapy?
Roger S; Potier M; Vandier C; Besson P; Le Guennec JY
Curr Pharm Des; 2006; 12(28):3681-95. PubMed ID: 17073667
[TBL] [Abstract][Full Text] [Related]
6. Voltage-gated sodium channel blockers for the treatment of neuropathic pain.
Cummins TR; Rush AM
Expert Rev Neurother; 2007 Nov; 7(11):1597-612. PubMed ID: 17997706
[TBL] [Abstract][Full Text] [Related]
7. Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3.
Anderson JD; Hansen TP; Lenkowski PW; Walls AM; Choudhury IM; Schenck HA; Friehling M; Höll GM; Patel MK; Sikes RA; Brown ML
Mol Cancer Ther; 2003 Nov; 2(11):1149-54. PubMed ID: 14617788
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric synthesis and evaluation of a hydroxyphenylamide voltage-gated sodium channel blocker in human prostate cancer xenografts.
Davis GC; Kong Y; Paige M; Li Z; Merrick EC; Hansen T; Suy S; Wang K; Dakshanamurthy S; Cordova A; McManus OB; Williams BS; Chruszcz M; Minor W; Patel MK; Brown ML
Bioorg Med Chem; 2012 Mar; 20(6):2180-8. PubMed ID: 22364743
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology of voltage-gated sodium channels in sensory neurones.
Docherty RJ; Farmer CE
Handb Exp Pharmacol; 2009; (194):519-61. PubMed ID: 19655117
[TBL] [Abstract][Full Text] [Related]
10. Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases.
Tarnawa I; Bölcskei H; Kocsis P
Recent Pat CNS Drug Discov; 2007 Jan; 2(1):57-78. PubMed ID: 18221218
[TBL] [Abstract][Full Text] [Related]
11. Voltage-gated sodium channel activity promotes prostate cancer metastasis in vivo.
Yildirim S; Altun S; Gumushan H; Patel A; Djamgoz MBA
Cancer Lett; 2012 Oct; 323(1):58-61. PubMed ID: 22484465
[TBL] [Abstract][Full Text] [Related]
12. Ion channels as molecular targets in prostate cancer.
Trepel JB
Clin Prostate Cancer; 2003 Dec; 2(3):188-9. PubMed ID: 15040864
[No Abstract] [Full Text] [Related]
13. Persistent current blockers of voltage-gated sodium channels: a clinical opportunity for controlling metastatic disease.
Djamgoz MB; Onkal R
Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):66-84. PubMed ID: 23116083
[TBL] [Abstract][Full Text] [Related]
14. Voltage-gated Na+ channels confer invasive properties on human prostate cancer cells.
Bennett ES; Smith BA; Harper JM
Pflugers Arch; 2004 Mar; 447(6):908-14. PubMed ID: 14677067
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer.
Yang M; Kozminski DJ; Wold LA; Modak R; Calhoun JD; Isom LL; Brackenbury WJ
Breast Cancer Res Treat; 2012 Jul; 134(2):603-15. PubMed ID: 22678159
[TBL] [Abstract][Full Text] [Related]
16. Voltage-gated sodium channel blockers for the treatment of chronic pain.
Matulenko MA; Scanio MJ; Kort ME
Curr Top Med Chem; 2009; 9(4):362-76. PubMed ID: 19442207
[TBL] [Abstract][Full Text] [Related]
17. The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis.
Nelson M; Yang M; Dowle AA; Thomas JR; Brackenbury WJ
Mol Cancer; 2015 Jan; 14(1):13. PubMed ID: 25623198
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of sodium channel blockers by membrane potential measurements in cerebellar neurons: prediction of compound preference for the open/inactivated state.
Kolok S; Nagy J; Szombathelyi Z; Tarnawa I
Neurochem Int; 2006 Nov; 49(6):593-604. PubMed ID: 16777267
[TBL] [Abstract][Full Text] [Related]
19. Effect of Voltage-Gated Sodium Channel Inhibitors on the Metastatic Behavior of Prostate Cancer Cells: A Meta-Analysis.
Yildirim-Kahriman S
Pak J Biol Sci; 2023 Jul; 26(8):419-426. PubMed ID: 37937335
[TBL] [Abstract][Full Text] [Related]
20. Effects of voltage-gated ion channel modulators on rat prostatic cancer cell proliferation: comparison of strongly and weakly metastatic cell lines.
Fraser SP; Grimes JA; Djamgoz MB
Prostate; 2000 Jun; 44(1):61-76. PubMed ID: 10861759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
